Trial reportJournal of the American Heart Association2025
Time to Endovascular Treatment and Clinical Outcome in Acute Ischemic Stroke With M2-Segment Occlusion.
Trial report in Journal of the American Heart Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Treatment time metrics and functional outcomes after endovascular thrombectomy in routine clinical practice.Frontiers in neurology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn large vessel occlusion (LVO) stroke, shorter time from stroke onset to endovascular thrombectomy (EVT), and faster recanalization in the early window (<6 hours from last seen well) are associated with better outcomes. This association is less well known for patients with M2 occlusions.
methodsWe conducted a pooled analysis of the MR CLEAN (Multicenter Randomized Clinical Trial of Endovascular Treatment of Acute Ischemic Stroke in the Netherlands) MED and NO-IV trials and analyzed the effect of time delay in EVT-treated LVO (grouped as intracranial internal carotid artery (ICA), ICA-Terminus, or M1-segment) and M2 occlusion patients with known stroke onset times. The primary outcome was the ordinal 90-day modified Rankin Scale score. Secondary outcomes included 90-day functional independence (modified Rankin Scale score 0-2) and mortality.
resultsWe included 94 patients with M2 occlusions and 423 with LVOs. In LVOs, longer times between stroke onset to start of EVT or to successful recanalization were associated with worse functional outcomes (adjusted common odds ratio [acOR], 0.92 [ 95% CI, 0.87-0.98] and acOR, 0.91 [95% CI, 0.86-0.95] per 15 minutes, respectively). Every 15-minute delay to start of EVT reduced the probability of functional independence by 2.3%. For M2 occlusions, no significant association was found between time to EVT or successful recanalization and functional outcome (acOR, 1.09 [95% CI, 0.97-1.22] and acOR, 1.04 [95% CI, 0.92-1.19] per 15 minutes). Patients with LVOs showed a significant 0.7% increased probability of 90-day mortality per 15-minute delay in the start of EVT, whereas patients with M2 occlusions showed no significant association.
conclusionsTreatment delays worsen functional outcomes in patients with LVOs. However, this was not shown in patients with M2 occlusions, suggesting that outcomes after EVT for patients with M2 occlusions in the early window depend less on time to treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.